
Sign up to save your podcasts
Or


Gemini Therapeutics CEO Jason Meyenburg share his thoughts about leadership in biopharma with BioBoss host John Simboli. Jason also discusses Gemini Therapeutics pioneering approach to developing precision medicines by leveraging genetics to work in diseases like dry AMD and linked diseases that have limited or no solutions.
By John Simboli5
77 ratings
Gemini Therapeutics CEO Jason Meyenburg share his thoughts about leadership in biopharma with BioBoss host John Simboli. Jason also discusses Gemini Therapeutics pioneering approach to developing precision medicines by leveraging genetics to work in diseases like dry AMD and linked diseases that have limited or no solutions.

3,067 Listeners

1,943 Listeners

1,093 Listeners

2,364 Listeners

949 Listeners

795 Listeners

123 Listeners

321 Listeners

6,071 Listeners

94 Listeners

9,997 Listeners

519 Listeners

146 Listeners

249 Listeners

180 Listeners